Cystic Fibrosis (CF) Diagnostics Market: By Test Type (Antenatal Testing, Carrier Testing, Sweat Tests, CFTR-Related Metabolic Syndrome (CRMS), Newborn screening, Prenatal Screening), By Product Type (Diagnostic Kits, Reagents, and Others), By End User (Hospitals and Diagnostic Centers) and Geography.

Purchase Option

$ 4400
$ 6600
$ 8900

Cystic fibrosis (CF) diagnostics market size was valued at USD 7.13 billion in 2022, growing at a CAGR of 18% from 2023-29. Cystic fibrosis (CF) is a chronic, genetic disease that causes persistent lung infections and limits the ability to breathe over time. Several mutations in the gene is responsible for Cystic fibrosis that encodes cystic fibrosis transmembrane conductance regulator (CFTR) protein. Patients with CF have inherited two copies of the defective CF gene one copy from each parent. Both parents must have at least one copy of the defective gene. Currently, there are approximately 70,000 people who are suffering from cystic fibrosis worldwide, according to the Cystic Fibrosis Foundation (CFF). Some of the popular methods of diagnosis are antenatal testing, carrier testing, and other tests such as genetic tests and sweat tests According to Cystic Fibrosis Foundation, the incidence of these hereditary disorders is constantly growing. Nonprofit organizations are investing huge amounts of funds to find various therapeutics for CF and to support research & developmental activities. 

Cystic Fibrosis (CF) Diagnostics Market Key Developments: 

In February 2018, Luminex's xTAG Cystic Fibrosis 71 Kit v2 was approved for sale with LICENSALE.COM in Brazil. In March 2017, Elucigene Diagnostics announced the official launch of a new CF-Italia kit (CF1ITB1). In April 2017, Elucigene Diagnostics partnered with Southern Cross Diagnostics in order to expand in Australia and New Zealand markets.

Cystic Fibrosis Cf Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

18%

Largest Market

North America

Fastest Growing Market

Europe
Cystic Fibrosis (CF) Diagnostics Market Dynamics

The major driver for the market is improved diagnostic technologies. Increase in investment and awareness about genetic diseases are aiding in development of diagnostic technologies, which will fuel the market growth. The high cost of the drugs and treatment may hamper the growth of the market. The global cystic fibrosis diagnostics market is expected to witness tremendous growth. Novel diagnostic tools for cystic fibrosis are being developed. The scientists at Stanford University, have developed a DNA test for the accurate and comprehensive screening of newborns for cystic fibrosis. By this test the next-generation DNA sequencing can be identified and this test is considered to be less expensive and less time-consuming technology.

Cystic Fibrosis Cf Diagnostics Market Segmentation

By Test Type
  • Antenatal Testing
  • Carrier Testing
  • Sweat Tests
  • CFTR-Related Metabolic Syndrome (CRMS)
  • Newborn Screening
  • Prenatal Screening
By Product Type
  • Diagnostic Kits
  • Reagents
  • Others
By End User
  • Hospital
  • Diagnostic centers
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa.

Frequently Asked Questions

The cystic fibrosis (CF) diagnostics market size was valued at USD 7.13 billion in 2022.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

The cystic fibrosis (CF) diagnostics market key players are: Elucigene, Asper Biogene, ELITechGroup, Natera, Inc., Randox Laboratories Ltd., Luminex Corporation, Appolon Bioteck, Arazy Group, Illumina Inc.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  1. Executive Summary
  2. Global Cystic Fibrosis (CF) Diagnostics Market Introduction
    • Global Cystic Fibrosis (CF) Diagnostics Market - Taxonomy
    • Global Cystic Fibrosis (CF) Diagnostics Market -Definitions
      • Test Type
      • Product Type
      • End User
  1. Global Cystic Fibrosis (CF) Diagnostics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Cystic Fibrosis (CF) Diagnostics Market Dynamic Factors - Impact Analysis
    • Global Cystic Fibrosis (CF) Diagnostics Market - Competition Landscape
    • Epidemiology
  2. Global Cystic Fibrosis (CF) Diagnostics Market Analysis,2018 - 2022 and Forecast, 2023 - 2029
    • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Cystic Fibrosis (CF) Diagnostics Market, By Test Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Antenatal Testing
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Carrier Testing
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Sweat Tests
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • CFTR-Related Metabolic Syndrome (CRMS)
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Newborn Screening
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Prenatal Screening
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cystic Fibrosis (CF) Diagnostics Market Forecast, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029
    • Diagnostic Kits
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Reagents
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cystic Fibrosis (CF) Diagnostics Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Hospital
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic centers
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Cystic Fibrosis (CF) Diagnostics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Cystic Fibrosis (CF) Diagnostics Market - Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Region, 2023 - 2029
  2. North America Cystic Fibrosis (CF) Diagnostics MarketAnalysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis 2016 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Cystic Fibrosis (CF) Diagnostics Market - Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2023 - 2029
    • North America Cystic Fibrosis (CF) Diagnostics Market Dynamics - Trends
  3. Europe Cystic Fibrosis (CF) Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Cystic Fibrosis (CF) Diagnostics Market - Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2023 - 2029
    • Europe Cystic Fibrosis (CF) Diagnostics Market Dynamics - Trends
  4. Asia-Pacific Cystic Fibrosis (CF) Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Cystic Fibrosis (CF) Diagnostics Market - Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2023 - 2029
    • Asia-Pacific Cystic Fibrosis (CF) Diagnostics Market Dynamics - Trends
  5. Latin America Cystic Fibrosis (CF) Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Cystic Fibrosis (CF) Diagnostics Market - Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2023 - 2029
    • Latin America Cystic Fibrosis (CF) Diagnostics Market Dynamics - Trends
  6. Middle East and Africa Cystic Fibrosis (CF) Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Antenatal Testing
      • Carrier Testing
      • Sweat Tests
      • CFTR-Related Metabolic Syndrome (CRMS)
      • Newborn Screening
      • Prenatal Screening
    • Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Diagnostic Kits
      • Reagents
      • Others
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital
      • Diagnostic centers
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Cystic Fibrosis (CF) Diagnostics Market - Opportunity Analysis Index, By Test Type, By Product Type, By End User, and Country, 2023 - 2029
    • MEA Cystic Fibrosis (CF) Diagnostics Market Dynamics - Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Test Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Elucigene
      • Asper Biogene
      • ELITechGroup
      • Natera, Inc.
      • Randox Laboratories Ltd.
      • Luminex Corporation
      • Appolon Bioteck
      • Arazy Group
      • Illumina Inc.
  1. Research Methodology
  2. Key Assumptions and Acronyms
  • Elucigene
  • Asper Biogene
  • ELITechGroup
  • Natera, Inc.
  • Randox Laboratories Ltd.
  • Luminex Corporation
  • Appolon Bioteck
  • Arazy Group
  • Illumina Inc.

Adjacent Markets